Status:
UNKNOWN
Total Splenectomy vs Partial Splenectomy in Non-malignant Hemoglobinopathies : Study Comparing the Effectiveness
Lead Sponsor:
University Hospital, Montpellier
Conditions:
Splenectomy; Status
Eligibility:
All Genders
Up to 18 years
Brief Summary
Partial splenectomy or total splenectomy are the two surgical treatment of non-malignant hemoglobinoptahie. The aim of this treatment is to decrease transfusion. The main risk is infectious in total s...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Children between 0- 18 years olds
- Total or partial splenectomy
- Non malignant hémoglobinopathies
- Exclusion criteria:
- \- Total or partial splenectomy outside of non malignant hemoglobinopathies
Exclusion
Key Trial Info
Start Date :
January 16 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 30 2022
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT05184647
Start Date
January 16 2022
End Date
December 30 2022
Last Update
January 11 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University hospital of Montpellier
Montpellier, France, 34295